Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
17 hedge funds and large institutions have $52.3K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
19% less funds holding
Funds holding: 21 → 17 (-4)
75% less capital invested
Capital invested by funds: $213K → $52.3K (-$160K)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$5.18K |
| 2 |
Neuberger Berman Group
New York
|
+$1.19K |
| 3 |
BHMP
Bardin Hill Management Partners
New York
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$25.6K |
| 2 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$452 |
| 3 |
LCG
Luxor Capital Group
New York
|
-$9 |
CTV.WS Hedge Fund Activity: Q4 2023 in Review
17 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q4 2023, worth a combined $52.3K — down 75% from $213K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CTV.WS and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Wolverine Asset Management, adding an estimated $5.18K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $25.6K sold.
- 17 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q4 2023, down from 21 in Q3 2023.
- Funds reported $52.3K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2023, down 75% quarter-over-quarter.
- 0 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2023 was Wolverine Asset Management, an estimated $5.18K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q4 2023 was Boothbay Fund Management, an estimated $25.6K sold.
Based on aggregated 13F filings for Q4 2023.